The recombinant herpes zoster vaccine is effective in older adults regardless of a patient’s immunocompromised status, based on data from more than 3 million adults aged 65 years or older.
Today, we are continuing our updates from the recent American Headache Society annual meeting.
Andrew Wilner is an associate professor of neurology at the University of Tennessee Health Science Center, Memphis, and a seasoned neurologist and epilepsy expert who has mastered the less conventional locum career path.
For older adults, the vaccine against respiratory syncytial virus (RSV) appears to be most effective in the first year after administration, according to new research that shows the benefits of the immunization fall roughly 60% within about 1.5 years.
Andrew N. Wilner, MD: Welcome to Medscape. I’m your host, Dr Andrew Wilner.
Enhanced navigation shortens time until guideline-adherent, postoperative radiotherapy (PORT) among patients with head and neck squamous cell carcinoma (HNSCC) compared with standard navigation, according to a study.
A flat 0° head positioning before thrombectomy was associated with a significantly less risk for early neurologic deterioration and all-cause mortality than a conventional 30° head elevation in adults with large vessel occlusion (LVO) stroke, a new study showed.
We’ve long known that migraine is an insidious disease. Patients with a variety of existing illnesses — atopic disorders, cardiovascular diseases, and sleep and/or psychiatric disorders — are at a risk for migraine.
